Importantly, we observed a significant increase in STMN1 expression in NEPC compared to prostate adenocarcinoma, suggesting its potential role as a diagnostic and prognostic marker for advanced PCa. The gene discussed is STMN1; the disease is prostate adenocarcinoma.